Funding for this research was provided by:
National Health and Medical Research Council
Received: 1 March 2020
Accepted: 1 June 2020
First Online: 11 June 2020
Ethics approval and consent to participate
: Mouse PDX experiments were conducted under the Garvan Institute ethical approval number 12/11. Breast cancer cohorts were obtained under the Garvan Institute ethical approval number HREC 08/145. Ovarian cancer cohort was obtained under the Human Research Ethics Committee of the Sydney South East Area Hospital Service Northern Section (00/115).
: Not applicable.
: The authors declare no competing interests.